MDCX · Insider Trading
Medicus Pharma Ltd. Common Stock
Every open-market purchase and sale reported by MDCX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | Edward J. Brennan | Chief Scientific Officer | A | +588,235 | +$100.29K |
| 2026-09-08 | Carolyn F. Bonner | President and CFO | A | +1,470,588 | +$250.74K |
| 2026-09-08 | Raza Bokhari | Chief Executive Officer | A | +2,941,176 | +$501.47K |
| 2026-09-08 | Faisal Mehmud | Chief Medical Officer | A | +1,470,588 | +$250.74K |
| 2026-09-08 | Andrew Alasdair Smith | Chief Operating Officer | A | +735,294 | +$125.37K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Raza Bokhari | Chief Executive Officer | 58,824 | $148.82K |
| Carolyn F. Bonner | President and CFO | 29,790 | $75.37K |
| Faisal Mehmud | Chief Medical Officer | 29,412 | $74.41K |
| Andrew Alasdair Smith | Chief Operating Officer | 14,709 | $37.21K |
| Edward J. Brennan | Chief Scientific Officer | 13,495 | $34.14K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MDCX quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.